Day: August 28, 2020

BOGOTÁ, Colombia, Aug. 28, 2020 (GLOBE NEWSWIRE) — Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the “Company”) (TSXV: MCCN), a leading Colombian and globally integrated cannabis company, is pleased to announce that it has closed on the first tranche of its previously announced offering of convertible debentures, raising gross aggregate proceeds of approximately $1 million, being the full amount previously disclosed. The offering consists of convertible secured debentures (the “Debentures”). The Debentures are convertible into common shares in the capital of the Company (“Common Shares”) on the following terms: the Debentures will be convertible into Common Shares at a price of $0.20 per share and will have a term of two (2) years from the date of issuance, with interest payable twice yearly of fourteen percent (14%) per annum...

Base EBITDA from continuing operations of $40.5 million, an increase of 67% over the comparable prior year period$136.3 million Base gross margin, an increase of 3% over the comparable prior year period Reaffirms Base EBITDA guidance range of $130 million to $160 million for fiscal year 2021Strong stakeholder approval of the Recapitalization PlanTORONTO, Aug. 28, 2020 (GLOBE NEWSWIRE) — Just Energy Group Inc. (“Just Energy” or the “Company”) (TSX:JE; NYSE:JE), a retail energy provider specializing in electricity and natural gas commodities, renewable energy options and carbon offsets, announced its first quarter results for fiscal year 2021.“We began fiscal year 2021 with a strong financial and operational performance despite on-going challenges brought on by the COVID-19 pandemic,” said Just Energy’s President and Chief Executive...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Aug. 28, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap”) (CSE:QSC; FRA:34C1) is pleased to announce the sale by MTJR, Inc. of 750,000 PCL Rapid Gold COVID-19 IgG/IgM Antibody tests to Breeze Laboratories in Colombia. QuestCap has a 40% profit sharing agreement with MTJR.“As a company focused on COVID-19 testing, we feel it is important to support testing efforts in countries that are still trying to flatten the curve. With Colombia ranked as number three in fatalities worldwide by the World Health Organization, it is clear we can make a difference. Our efforts and that of our partners, MTJR will both help the people of Colombia, while also benefiting QuestCap shareholders,” commented Doug Sommerville, QuestCap CEO.MTJR has...

MINNEAPOLIS, Aug. 28, 2020 (GLOBE NEWSWIRE) — Sun BioPharma, Inc. (OTCQB:SNBP Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, today announced the pricing of an underwritten public offering of 2,545,454 shares of common stock and the same number of warrants to purchase shares of common stock for a price to the public of $4.125 per share and warrant.  Gross proceeds to the company are expected to be approximately $10.5 million. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $4.54 per share.Sun BioPharma also announced that, in connection with the offering, its common stock has been approved for listing on the Nasdaq Capital Market and will begin trading on the Nasdaq Capital Market under...

HARRISBURG, Pa., Aug. 28, 2020 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (Nasdaq: OLLI) announced today that the Company will be participating in the 27th Annual Goldman Sachs Virtual Retailing Conference on Wednesday, September 10, 2020 at 12:50 PM ET. Attending for Ollie’s will be John Swygert, President and Chief Executive Officer, and Jay Stasz, Senior Vice President and Chief Financial Officer.The audio portion of the presentation will be webcast live over the internet and can be accessed by logging on to the Investor Relations section on the Company’s website at http://investors.ollies.us/. An online archive will be available for a period of 90 days following the presentation.About Ollie’sWe are a highly differentiated and fast growing, extreme value retailer of brand name merchandise at drastically reduced...

Boliga Gruppen A/SCVR.nr. 25078780(“Selskabet“)Fondsbørsmeddelelse nr. 9/2020Resume for 1. halvår 2020Koncernen opnåede i 1. halvår 2020 en omsætning på 26,7 mio. kr., hvilket er en stigning på 2,6 mio. kr. mod samme perio­de sidste år af fortsættende aktiviteter. Omsætningen følger de udmeldte forventninger til 2020. Koncernens resultat før skat af fortsættende aktiviteter blev 5,4 mio. kr. mod 1,9 mio. kr. i samme periode 2019. Resultatet følger de senest udmeld­te forventninger.Begivenheder i 1. halvår 20201. halvår af 2020 har været præget af covid-19, der har påvirket omsætningen negativt. Reduktioner i omkostningerne har dog kompenseret herfor.Boliga.dk har i første halvår lanceret Boliga Byg Hus. Ambitionen er at samle alle landets hus- og byggefirmaer og skabe en samlet indgang til husbyggermarkedet. Byg Hus-universet...

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

MONTRÉAL, Aug. 28, 2020 (GLOBE NEWSWIRE) — Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or the “Company”) announces that it has entered into a loan agreement with AIP Convertible Private Debt Fund L.P. (the “Lender”) for a secured loan in the principal amount of CAD$4,000,000 (the “Loan”). The Loan will have a term of 24 months and will bear interest at the rate of 17% per annum.  The Loan will be secured by a general security agreement on all of the present and after-acquired property of the Company. On closing, the Company will pay to the Lender (i) a facility fee of CAD$200,000; (ii) a closing fee of CAD$250,000; and (ii) a monitoring fee of CAD$75,000, in respect of the Loan. Upon approval of the TSX Venture Exchange (the “TSXV”), the Lender shall also receive a bonus of 46,333,333 common shares (the “Bonus...

MALVERN, Pa., Aug. 28, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, today announced it will present at the LD 500 Virtual Investor Conference on Friday, September 4 at 11 a.m. ET.Sanjay Subramanian, Chief Financial Officer, will present virtually to an online audience highlighting Ocugen’s breakthrough gene therapy platform as well as its novel biologic product candidate.  He will also highlight Ocugen’s lead product candidate, OCU400, which has the potential to treat many forms of retinitis pigmentosa and just received its fourth FDA orphan drug designation. Mr. Subramanian will share Ocugen’s recent accomplishments and its upcoming planned near and medium-term milestones.Presentation...